Noradrenergic function in suicide

scientific article published on January 2007

Noradrenergic function in suicide is …
instance of (P31):
scholarly articleQ13442814
review articleQ7318358

External links are
P356DOI10.1080/13811110701402587
P8608Fatcat IDrelease_566ntts3c5hmxkkrkpkxdgxyn4
P698PubMed publication ID17558608

P2093author name stringGhanshyam N Pandey
Yogesh Dwivedi
P2860cites workA prospective study of the association of cerebrospinal fluid monoamine metabolite levels with lethality of suicide attempts in patients with bipolar disorderQ48396554
Determination of monoamine and monoamine metabolites in the human brain: post mortem studies in a group of suicides and in a control groupQ48409708
Studies of amine metabolites in depressed patients. Relationship to suicidal behaviorQ48423019
The effect of tri-iodothyronine in combination with impramine on [3H]-cyclic AMP production in slices of rat cerebral cortexQ48503127
Brain alpha-adrenoceptors in depressed suicidesQ48706127
Autoradiographic demonstration of increased serotonin 5-HT2 and beta-adrenergic receptor binding sites in the brain of suicide victimsQ48869670
Brain region specific alterations in the protein and mRNA levels of protein kinase A subunits in the post-mortem brain of teenage suicide victims.Q48882461
Relationships of age and axis I diagnoses in victims of completed suicide: a psychological autopsy study.Q51026926
Symptom patterns in unipolar and bipolar depression correlating with monoamine metabolites in the cerebrospinal fluid: II. SuicideQ51264834
The norepinephrine-to-epinephrine ratio in patients with a history of suicide attempts.Q52089981
Fewer pigmented locus coeruleus neurons in suicide victims: Preliminary resultsQ58614294
Suicide as an outcome for mental disorders. A meta-analysisQ28244203
Imidazoline receptors and human brain disordersQ33693078
Role of the serotonergic system in the pathogenesis of major depression and suicidal behaviorQ33702882
Neural plasticity to stress and antidepressant treatmentQ33772697
Second messenger-regulated protein kinases in the brain: their functional role and the action of antidepressant drugsQ33806945
Stress system alterations and mood disorders in suicidal patients. A reviewQ33935633
Specificity in the cAMP/PKA signaling pathway. Differential expression,regulation, and subcellular localization of subunits of PKA.Q33988753
Serine/threonine kinases as molecular targets of antidepressants: implications for pharmacological treatment and pathophysiology of affective disordersQ34228106
Action of various antidepressant treatments reduces reactivity of noradrenergic cyclic AMP-generating system in limbic forebrainQ34575517
Studies on leukocyte beta-adrenergic receptors in depression: a critical appraisalQ37889682
Subtypes of alpha 2-adrenoceptors: pharmacological and molecular biological evidence convergeQ39339158
Aggression in humans correlates with cerebrospinal fluid amine metabolitesQ39595679
Development of β-adrenergic receptor subsensitivity by antidepressantsQ40093742
Beta-adrenergic receptor function in affective illnessQ40221614
Life stress, depression and attempted suicideQ40643386
Subsensitivity of adenylyl cyclase-coupled receptors on mononuclear leukocytes from drug-free inpatients with a major depressive episodeQ40878526
The catalytic subunit of cAMP-dependent protein kinase induces expression of genes containing cAMP-responsive enhancer elementsQ41337116
Increased serotonin2 and beta-adrenergic receptor binding in the frontal cortices of suicide victimsQ41367803
Brain beta-adrenoceptor binding sites in antidepressant-free depressed suicide victimsQ42064779
Increased 3H-clonidine binding in the platelets of patients with depressive and schizophrenic disordersQ43412883
Cerebrospinal fluid monoamine metabolites and suicidal behavior in depressed patients. A 5-year follow-up studyQ43620646
Autoradiographic analysis of alpha 1-noradrenergic receptors in the human brain postmortem. Effect of suicideQ44000456
Biogenic amine turnover and serum cholesterol in suicide attemptQ44022146
A study on nitric oxide, beta-adrenergic receptors and antioxidant status in the polymorphonuclear leukocytes from the patients of depressionQ44120363
Elevated agonist binding to alpha2-adrenoceptors in the locus coeruleus in major depressionQ44315062
Increased mRNA expression of alpha2A-adrenoceptors, serotonin receptors and mu-opioid receptors in the brains of suicide victimsQ44345756
Abnormal expression and functional characteristics of cyclic adenosine monophosphate response element binding protein in postmortem brain of suicide subjectsQ44352569
Altered gene expression of brain-derived neurotrophic factor and receptor tyrosine kinase B in postmortem brain of suicide subjectsQ44545444
Protein kinase A in postmortem brain of depressed suicide victims: altered expression of specific regulatory and catalytic subunitsQ44742894
Serotonergic and noradrenergic neurobiology of alcoholic suicideQ44913233
Brainβ-adrenoceptor binding sites in depressed suicide victims: effects of antidepressant treatmentQ45765138
Reduced tyrosine hydroxylase immunoreactivity in locus coeruleus of suicide victimsQ46115958
Decreased catalytic activity and expression of protein kinase C isozymes in teenage suicide victims: a postmortem brain studyQ47240779
Neurobiology of serotonin in depression and suicideQ48003233
Tyrosine hydroxylase immunoreactivity in the locus coeruleus is reduced in depressed non-suicidal patients but normal in depressed suicide patientsQ48134657
Coupling efficiency of brain β-adrenergic receptors to Gs protein in suicide, alcoholism and control subjectsQ48137952
Brain noradrenergic receptors in major depression and schizophreniaQ48179741
P433issue3
P921main subjectsuicideQ10737
P304page(s)235-246
P577publication date2007-01-01
P1433published inArchives of Suicide ResearchQ15752087
P1476titleNoradrenergic function in suicide
P478volume11

Reverse relations

cites work (P2860)
Q34520517Elucidating biological risk factors in suicide: Role of protein kinase A
Q37173418Lower CSF MHPG predicts short-term risk for suicide attempt
Q37178455Neural response to catecholamine depletion in unmedicated subjects with major depressive disorder in remission and healthy subjects
Q36786262Pain and suicidality: insights from reward and addiction neuroscience.
Q34145754Pathophysiology of depression: do we have any solid evidence of interest to clinicians?
Q34066818Pharmacogenomics of suicidal events
Q26742185Protein Kinase A and Anxiety-Related Behaviors: A Mini-Review
Q37148543Stress, genes and the biology of suicidal behavior
Q37639841The Life Span Model of Suicide and Its Neurobiological Foundation

Search more.